| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 114 |
| 1 | SILDENAFIL CITRATE | 80 |
| 2 | TREPROSTINIL | 78 |
| 3 | TADALAFIL | 75 |
| 4 | AMBRISENTAN | 68 |
| 5 | MACITENTAN | 61 |
| 6 | FUROSEMIDE | 45 |
| 7 | SILDENAFIL | 44 |
| 8 | BOSENTAN | 41 |
| 9 | FOSCARBIDOPA/FOSLEVODOPA | 40 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 114 | 0.0087 |
| 1 | HISTAMINE | 1 | 0.0069 |
| 2 | FOSCARBIDOPA/FOSLEVODOPA | 40 | 0.0045 |
| 3 | CLEVIDIPINE | 1 | 0.0027 |
| 4 | TRABECTEDIN | 6 | 0.0026 |
| 5 | CERLIPONASE ALFA | 1 | 0.0019 |
| 6 | HEMIN | 1 | 0.0017 |
| 7 | SODIUM CITRATE | 2 | 0.0016 |
| 8 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 1 | 0.0016 |
| 9 | PSYLLIUM HUSK | 2 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 175 |
| 1 | Endothelin Receptor Antagonist [EPC] | 124 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 94 |
| 3 | Loop Diuretic [EPC] | 53 |
| 4 | Corticosteroid [EPC] | 51 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 36 |
| 7 | Factor Xa Inhibitor [EPC] | 31 |
| 8 | Aldosterone Antagonist [EPC] | 27 |
| 9 | Provitamin D2 Compound [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 19 | 0.0014 |
| 1 | Prostacycline Vasodilator [EPC] | 175 | 0.0013 |
| 2 | Provitamin D2 Compound [EPC] | 26 | 0.0009 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 94 | 0.0007 |
| 4 | Endothelin Receptor Antagonist [EPC] | 124 | 0.0006 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 3 | 0.0006 |
| 6 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 7 | Soluble Guanylate Cyclase Stimulator [EPC] | 19 | 0.0006 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 7 | 0.0005 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |